Discontinuation of Statin Therapy Deadly For Rheumatoid Arthritis Patients?

.

Discontinuation of Statin Therapy Deadly For Rheumatoid Arthritis Patients?

A new study proposed has underlined that people who are diagnosed of Rheumatoid Arthritis (RA), in case, discontinue their statin therapy then, there are higher chances that they even fall to severe heart problems. The study should actually be considered as a warning for those suffering from rheumatoid arthritis.

The study conducted by American College of Rheumatology, was carried out for almost four years, analyzing people suffering from RA. During the research, it was observed that around 45% of people with RA discontinued their drugs statin at least once in the four years of the research.

As a consequence, 198 deaths were reported to be due to cardiovascular diseases out of the 467 deaths in total. It was hence, declared that patients, who are suffering from RA and are prescribed to undergo the therapy, should not discontinue it, else it can lead to cardiovascular diseases.

Lead author Mary De Vera, of the University Of British Columbia School of Population & Public Health and Arthritis Research Centre of Canada, said "Our study findings emphasise the importance of medication compliance in RA patients who are prescribed statins”.

Another study of the same kind conducted by Vancouver, Montreal and Boston researchers, also confirmed with their findings that RA patients who quit statin drugs had 79 % increased risk of death.


Latest News

Rise in Russian Arms Sales In spite of a Drop Globally
PetSmart Sells itself with an $8.3Billion Deal
Falling Oil Prices Result in a Drop in Stocks
Shares of Amaya Fall Due to Probe Conducted by Securities Regulators
Americans Consumers Display Confidence In the Market with Gain in Sales
It’s Time to Hurry Up to Enrol in the First Phase of Affordable Care Act Health
After Merger with Alliance Boots,	Walgreen CEO will Retire
Falling Fuel Prices Lift Airline Profits But No Respite in Fares Expected
Citigroup to Pay Likely $2.7B as Legal Charge
Michael Jeffries Retires as the CEO of Abercrombie & Fitch
Deutsche Bank in Trouble Again in the U.S. for Alleged Tax Scheme
Popular Demand Brings French Toast Crunch Back on the Shelves